214 related articles for article (PubMed ID: 24792871)
1. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.
Bruminhent J; Wang ZX; Hu C; Wagner J; Sunday R; Bobik B; Hegarty S; Keith S; Alpdogan S; Carabasi M; Filicko-O'Hara J; Flomenberg N; Kasner M; Outschoorn UM; Weiss M; Flomenberg P
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1329-34. PubMed ID: 24792871
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
3. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
Akahoshi Y; Kimura S; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Clin Transplant; 2016 Jun; 30(6):703-8. PubMed ID: 27019071
[TBL] [Abstract][Full Text] [Related]
4. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.
Zacharioudakis IM; Ziakas PD; Mylonakis E
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
[TBL] [Abstract][Full Text] [Related]
9. Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China.
Gu SL; Chen YB; Lv T; Zhang XW; Wei ZQ; Shen P; Li LJ
J Med Microbiol; 2015 Mar; 64(Pt 3):209-216. PubMed ID: 25596117
[TBL] [Abstract][Full Text] [Related]
10. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
[TBL] [Abstract][Full Text] [Related]
11. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
12. Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission.
Al-Rawahi GN; Al-Najjar A; McDonald R; Deyell RJ; Golding GR; Brant R; Tilley P; Thomas E; Rassekh SR; O'Gorman A; Wong P; Turnham L; Dobson S
Pediatr Blood Cancer; 2019 May; 66(5):e27604. PubMed ID: 30666782
[TBL] [Abstract][Full Text] [Related]
13. Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients.
Tschudin-Sutter S; Carroll KC; Tamma PD; Sudekum ML; Frei R; Widmer AF; Ellis BC; Bartlett J; Perl TM
Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1324-9. PubMed ID: 26223207
[TBL] [Abstract][Full Text] [Related]
14. Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant.
Kamboj M; Sheahan A; Sun J; Taur Y; Robilotti E; Babady E; Papanicolaou G; Jakubowski A; Pamer E; Sepkowitz K
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):8-15. PubMed ID: 26486102
[TBL] [Abstract][Full Text] [Related]
15. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
18. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
Longtin Y; Trottier S; Brochu G; Paquet-Bolduc B; Garenc C; Loungnarath V; Beaulieu C; Goulet D; Longtin J
Clin Infect Dis; 2013 Jan; 56(1):67-73. PubMed ID: 23011147
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.
Vehreschild MJ; Weitershagen D; Biehl LM; Tacke D; Waldschmidt D; Töx U; Wisplinghoff H; Von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ
Biol Blood Marrow Transplant; 2014 Jun; 20(6):823-8. PubMed ID: 24607558
[TBL] [Abstract][Full Text] [Related]
20. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.
Wilcox MH
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():13-20. PubMed ID: 23121550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]